中文簡(jiǎn)介
在過(guò)去的十年里,皮膚藥理學(xué)的研究有了很大的發(fā)展,新的和有前途的藥物和治療概念被定期引入。最近的例子包括免疫抑制劑,以及治療惡性黑色素瘤和傷口愈合的新戰(zhàn)略。在傳統(tǒng)的皮膚治療和護(hù)膚領(lǐng)域也有了新的概念,這些概念導(dǎo)致了諸如美國(guó)的“宇宙性”、日本的“準(zhǔn)藥物”等問(wèn)題的討論。歐盟化妝品條例第6修正案。有許多懸而未決的問(wèn)題反映了這一主題的重要性和建立一個(gè)新的國(guó)際科學(xué)論壇的必要性,以便能夠?qū)@些問(wèn)題進(jìn)行詳盡的討論。邀請(qǐng)皮膚科醫(yī)生、藥物化學(xué)家、藥理學(xué)家、毒理學(xué)家和其他對(duì)這一課題感興趣的人為這一激動(dòng)人心的項(xiàng)目作出貢獻(xiàn),并提交他們最好的研究成果供出版。
英文簡(jiǎn)介
In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as ‘cosmeceuticals’ in the United States, ‘quasi-drugs’ in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.
近年期刊自引率趨勢(shì)圖
JCR分區(qū)
JCR分區(qū)等級(jí) | JCR所屬學(xué)科 | 分區(qū) | 影響因子 |
Q2 | DERMATOLOGY | Q2 | 3.014 |
PHARMACOLOGY & PHARMACY | Q3 |
近年期刊影響因子趨勢(shì)圖
CiteScore數(shù)值
CiteScore | SJR | SNIP | 學(xué)科類(lèi)別 | 分區(qū) | 排名 | 百分位 |
6.40 | 0.860 | 1.549 | 大類(lèi):Medicine 小類(lèi):Dermatology | Q1 | 13 / 126 |
90% |
大類(lèi):Medicine 小類(lèi):Pharmacology | Q2 | 90 / 303 |
70% |
|||
大類(lèi):Medicine 小類(lèi):Physiology | Q2 | 56 / 180 |
69% |
相關(guān)醫(yī)學(xué)SCI期刊推薦
SCI期刊欄目
SCI期刊 工程技術(shù) 物理 生物 化學(xué) 醫(yī)學(xué) 農(nóng)林科學(xué) 數(shù)學(xué) 地學(xué)天文 地學(xué) 環(huán)境科學(xué)與生態(tài)學(xué) 綜合性期刊 管理科學(xué) 社會(huì)科學(xué)
期刊論文百科問(wèn)答
copyright © www.56st48f.cn, All Rights Reserved
搜論文知識(shí)網(wǎng) 冀ICP備15021333號(hào)-3